Chronic resveratrol reverses a mild angiotensin II-induced pressor effect in a rat model

Autor: Gordish KL, Beierwaltes WH

Publikováno v: Integrated Blood Pressure Control, Vol 2016, Iss Issue 1, Pp 23-31 (2016)

Kevin L Gordish,1 William H Beierwaltes1,2 1Department of Physiology, Wayne State School of Medicine, 2Department of Internal Medicine, Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, MI, USA Abstract: Resveratrol is report

Externí odkaz: https://doaj.org/article/8c13cd4aac04494fa370e5593105f143

Impact of inhibition of the renin-angiotensin system on early cardiac and renal abnormalities in Sprague Dawley rats fed short-term high fructose plus high salt diet.

Autor: Siddiqui, Sharif Hasan, Pitpitan, Rebekah, Boychev, Boycho, Komnenov, Dragana, Rossi, Noreen F.

Publikováno v: Frontiers in Nutrition; 2024, p1-15, 15p

Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging.

Autor: Gordish KL; Dept. Internal Medicine, Hypertension and Vascular Research Div., Henry Ford Hospital, 7088 E&R Bldg., 2799 W. Grand Blvd., Detroit, MI 48202. wbeierw1@hfhs.org., Beierwaltes WH

Publikováno v: American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2014 Mar 01; Vol. 306 (5), pp. F542-50. Date of Electronic Publication: 2014 Jan 15.

Renal Farnesoid X Receptor improves high fructose-induced salt-sensitive hypertension in mice by inhibiting DNM3 to promote nitro oxide production.

Autor: Zhu Y; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine., Tao Y; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine., Wu C; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine., Zeng Y; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine., Du H; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine., Xiang Q; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine., Chen Y; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine., Zhu Q; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangdong Pharmaceutical University, Guangzhou, China., Wang L; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine.

Publikováno v: Journal of hypertension [J Hypertens] 2022 Aug 01; Vol. 40 (8), pp. 1577-1588. Date of Electronic Publication: 2022 Jul 05.

Vitamin D3 mitigates myopathy and metabolic dysfunction in rats with metabolic syndrome: the potential role of dipeptidyl peptidase-4.

Autor: Shoier NO; Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt., Ghareib SA; Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt., Kothayer H; Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt., Alsemeh AE; Human Anatomy and Embryology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt., El-Sayed SS; Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. ssothman@pharmacy.zu.edu.eg.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Oct 02. Date of Electronic Publication: 2024 Oct 02.